A new collaborative initiative is being launched in Montreal to guarantee that women who sustain traumatic brain injuries during intimate partner violence receive appropriate medical attention. The effort is coordinated by the West Island Women’s Shelter under the direction of Guylaine Simard and brings together researchers, doctors, social workers and police officers.
The partnership was announced Monday, June 29, 2026, as a response to growing evidence that brain injuries among victims of intimate partner violence are frequently overlooked. Studies have indicated that many survivors leave shelters with undiagnosed neurological damage, a condition that can worsen without timely treatment.
By linking the shelter’s frontline support with medical and investigative professionals, the group aims to create clear pathways for diagnosis and care. Social workers will identify signs of head trauma, researchers will contribute current findings on injury prevalence, doctors will provide clinical assessment and treatment, and police will ensure that incidents are documented and linked to appropriate legal processes.
The coordinated approach is intended to fill gaps that have historically left women without access to specialized neurological services. It also reflects a broader movement within Quebec’s health and social sectors to address the hidden consequences of domestic abuse. While the initiative is still in its early stages, the involvement of multiple agencies signals a commitment to systematic change.
The West Island Women’s Shelter, a long‑standing service for survivors in the West Island area, is positioning itself as a hub for this network. Guylaine Simard emphasized the need for a unified response, noting that early detection of brain injury can significantly improve recovery outcomes. The collaborative model may serve as a template for other communities seeking to integrate health care and protective services for intimate partner violence victims.
The program will begin implementation this month, with ongoing evaluation planned to measure its impact on diagnosis rates and treatment access for affected women in Montreal and the surrounding region.